Antibody-drug Conjugate Information

General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0MWSEV
ADC Name
NN-3201
Synonyms
NN 3201; NN-3201; NN3201
   Click to Show/Hide
Organization
Novelty Nobility, Inc.
Drug Status
Phase 1
Indication
In total 5 Indication(s)
Gastrointestinal stromal cancer
Phase 1
Clinical Trial
Kidney cancer
Phase 1
Clinical Trial
Lung cancer
Phase 1
Clinical Trial
Melanoma
Phase 1
Clinical Trial
Solid tumor
Phase 1
Clinical Trial
Drug-to-Antibody Ratio
4
Antibody Name
NN2101
  Antibody Info 
Antigen Name
Mast/stem cell growth factor receptor Kit (KIT)
  Antigen Info 
Payload Name
Monomethyl auristatin E
  Payload Info 
Therapeutic Target
Microtubule (MT)
  Target Info 
Conjugate Type
Reactive Cysteines